期刊文献+

TLSF_(JM)对Th1/Th2样细胞亚群比率的影响 被引量:3

The influnce of TLSF_(JM) on the proportion of Th1/Th2-like cell subsets
下载PDF
导出
摘要 目的 :探讨TLSFJM 对同种异体抗原活化的Th1/Th2样细胞亚群变化的影响。方法 :在混合淋巴细胞反应 (MLR)体系中加入TLSFJM 或IL 4 ,用细胞内免疫荧光染色结合流式细胞术分析TLSFJM 对Th1/Th2样细胞亚群比率的影响。结果 :在TLSFJM实验组中 ,活化淋巴母细胞分化为IFN γ+ 细胞的比率略有降低 (49.8%→ 4 3.1% ) ,IL 4 + 、IL 6 + 细胞的比率有明显降低 ,IL 4 + 细胞的比率由 75 .4 %降至 4 3.7% ,IL 6 + 细胞的比率由6 7.8%降至 5 2 .6 %。在未活化小淋巴细胞中 ,也观察到同样的趋势。结论 :TLSFJM 对Th1、Th2样细胞亚群都有抑制 ,但似乎主要作用于Th2样细胞亚群 。 AIM: To explore the influence of TLSFJM on the proportion of alloantigen activated Th1 and Th2 like cell subsets. METHODS: TLSFJM or IL 4 was added to mixed lymocyte reaction(MLR) system. The influnce of TLSFJM on the proportion of Th1 and Th2 like cell subsets was analyzed by intracellular immunofluorescence staining and FACS. RESULTS: In the TLSFJM group, the proportion of IFN γ + cells differentiated from activated lymphoblast descended from 49.8% to 43.1%, IL 4 + cells from 75.4% to 43.7% and IL 6 + cells from 67.8% to 52.6%. The similar tendency was also observed in the unactivated small lymphocytes. CONCLUSION: TLSFJM can inhibit both the Th1 and Th2 like cell subsets, but mainly inhibit the Th2 like cell subset, thereby reducing the proportion of Th2 like cell subsets.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2004年第3期334-336,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(No .30 0 0 0 1 50 )
关键词 TLSFJM TH1细胞 TH2细胞 TLSFJM Th1 cell Th2 cell
  • 相关文献

参考文献7

  • 1Sad S, Marcotte R, Mosmann TR. Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines[J]. Immunity, 1995, 2: 271-276.
  • 2Halverson DC, Schwartz JN, Carter C, et al. In vitro generation of allospecific human CD8+ T cells of Tc1 and Tc2 phenotype[J]. Blood, 1997, 90: 2089-2095.
  • 3Mosmann TR, Li L, Sad S, et al. Functions of CD8 T-cell subsets secreting different cytokine patterns[J]. Immunology, 1997, 9: 87-93.
  • 4Kemp RA, Ronchese F. Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity[J]. J Immunol, 2001, 167: 6497-6505.
  • 5Nagata K, Tanaka K, Ogawa K, et al. Selective expression of a novel surface molecule by human Th2 cells in vivo[J]. J Immunol, 1999, 162: 1278-1284.
  • 6申立中,金伯泉,夏海滨,朱勇,刘雪松.TLSF_(JM)对DNFB诱导的小鼠接触性皮炎和同种异体皮片移植排斥反应的抑制作用[J].细胞与分子免疫学杂志,1996,12(4):27-31. 被引量:9
  • 7李超乾,徐永健,钟小宁,杨丹蕾,刘先胜,熊维宁,张珍祥.不同Th1/Th2细胞免疫应答支气管肺泡灌洗液中细胞学的变化[J].细胞与分子免疫学杂志,2002,18(6):575-577. 被引量:23

二级参考文献6

共引文献30

同被引文献22

  • 1张圣林,邱法波,吴力群.Th1/Th2偏移与恶性肿瘤关系的研究进展[J].细胞与分子免疫学杂志,2005,21(B03):113-114. 被引量:21
  • 2孟凡凯,孙汉英,刘文励,周剑锋.再生障碍性贫血免疫学发病机制研究新进展[J].中华内科杂志,2005,44(10):789-790. 被引量:7
  • 3Eli FernandesJ L, Mamom RL, OrofrdJ L, et al. Increased Thl activity in patients with coronary artery disease [ J ]. Cytokine, 2004, 26 (3): 131-137.
  • 4De Palma R, Del Galdo F, Abbate G, et al. Patients with acute coronary syndrome show oligoclonal T-cell recruitment with in unstable plaque: Evidence for a local, intracoronary immunologic mechanism [J]. Circulation, 2006, 113(5) : 640 -646.
  • 5Steppich BA, Moog P, Matissek C, et al. Ctyokine porifles and T cell function in acute coomary syndormes[ J]. Atheorsclerosis, 2007, 190 (2) : 443 -451.
  • 6Paintlia AS, Paintlia MK, Singh I, et al. Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide 1-bet-D-ribofuranoside alleviates neuordegeneration in experimental autoimmune encephalomyelitis [ J ]. Am J Pathol, 2006, 169 ( 3 ) : 1012 - 1025.
  • 7Shimada K, Miyauchi K, Dmda H, et al. Early interveniton with atorvsatatin modulatesTH1/TH2 imbalance in patients with acute coronary syndrome : From bedsideto bench [ J ]. Cicrulation, 2004, 109 ( 18 ) : 213 -214.
  • 8Shimada K, ParkJ K, Dmda H. T helperl/T helepr2 balnace and HMGCoA redoctsae inhibitors in acute coronarysyn drome: statinsa Simmu-nomodulatory agents? [J] Eur Heart J, 2006, 27(11) : 2916 -2918.
  • 9Pervaiz S. RelatedResveratrol:from grapevines to mammalian biology[J]. FASEB J,2003,17:1975-1985.
  • 10Stewart JR,Artime MC,O'Brian CA. Resveratrol:a candidate nutritional substance for prostate cancer prevention[J]. J Nutr,2003,133:S2440-2443.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部